Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 15/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | DRD4 | P21917 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CFB | P00751 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13604783 | 0.88 | SLC6A4 (0.38) | SLC6A4SLC6A2SLC6A3DRD2DRD4 | |
| SCHEMBL13604964 | 0.86 | MAPK1 (0.43) | SLC6A4SLC6A2SLC6A3DRD2DRD4 | |
| SCHEMBL13604957 | 0.73 | MAPK1 (0.45) | SLC6A4CFB | |
| SCHEMBL13604963 | 0.68 | TNIK (0.39) | SLC6A4SLC6A2SLC6A3CFB | |
| SCHEMBL4490599 | 0.67 | SLC6A4 (0.45) | SLC6A4SLC6A2 | |
| SCHEMBL13604838 | 0.67 | MAPK1 (0.47) | SLC6A4SLC6A2SLC6A3CFB | |
| SCHEMBL3694945 | 0.65 | TDO2 (0.39) | SLC6A4SLC6A2SLC6A3DRD2DRD4 | |
| SCHEMBL27693921 | 0.65 | TDO2 (0.39) | SLC6A4SLC6A2SLC6A3DRD2DRD4 | |
| SCHEMBL16226580 | 0.65 | L3MBTL1 (0.50) | ALDH1A1CFBKDM4EMAPTKMT2A | |
| SCHEMBL3646740 | 0.64 | IMPDH2 (0.56) | SLC6A4KDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1851199-B1 | SUBSTITUTED BIS ARYL AND HETEROARYL COMPOUNDS AS SELECTIVE 5HT2A ANTAGONISTS | AVENTIS PHARMA INC (US) | 2012-05-16 | — | — | EP | disclosed |